It comes as an oral tablet. Gleevec is available as a generic drug called imatinib mesylate. For information about the dosage of Gleevec, including its strengths and how to take the drug ...

As a result, FDA has not approved Sun Pharma's Imatinib Mesylate Tablet products for this indication. For safety information please refer to U.S. Full Prescribing Information at www.imatinibrx.com ...

This is because the 400-mg tablets contain more of the drug’s active ingredient (imatinib mesylate). They’re also packaged differently. The 400-mg tablets come in blister packs and the 100-mg ...

Background and Objective: Imatinib mesylate is the first effective therapy for advanced unresectable gastrointestinal stromal tumours (GIST). Adoption of this therapy in clinical practice is ...

The recall involves various medications, such as Imatinib Mesylate Tablets 100 mg and 400 mg; Pregabalin Capsules 50 mg, 75 mg, 100 mg, and 150 mg; Sevelamer Carbonate Tablets 800 mg; as well as ...

29, 2017 /PRNewswire/ -- Mylan N.V. (NASDAQ, TASE: MYL) today announced the U.S. launch of Imatinib Mesylate Tablets, 100 mg and 400 mg, a generic version of Novartis's Gleevec® Tablets.

(RTTNews) - Dr. Reddy's Laboratories Ltd. (RDY) announced the launch of Imatinib Mesylate Tablets, USP, a therapeutic equivalent generic version of Gleevec Tablets in the U.S. market approved by ...

Shares of Shilpa Medicare rose 3.8 percent intraday Friday after company received US Food and Drug Administration (USFDA) approval for its ANDA, Imatinib Mesylate Tablets, 100 mg and 400 mg.

On December 4, 2015 Sun Pharmaceutical Industries Limited based in India received the US Food and Drug Administration (USFDA) approval to manufacture and market Imatinib Mesylate tablets in United ...

The information provided on this page is intended to serve as a comprehensive resource and should not be a substitute to professional medical advice. If you have concerns it is always best to ...

positive unrespectable and/or metastatic malignant gastrointestinal stromal tumors (GIST)." FDA has not approved Sun Pharma's Imatinib Mesylate Tablet products for this indication.